MK-0773 manufacturers
- MK-0773
-
- $10.00 / 1kg
-
2024-03-08
- CAS:606101-58-0
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 1000kg
- MK-0773
-
- $10.00 / 1kg
-
2024-03-08
- CAS:606101-58-0
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 1000kg
- MK-0773
-
- $0.00 / 1kg
-
2023-11-27
- CAS:606101-58-0
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 20 tons
|
| | MK-0773 Basic information |
| Product Name: | MK-0773 | | Synonyms: | MK-0773;PF 05314882;PF05314882;PF-05314882;N-(3H-Imidazo[4,5-b]pyridin-2-ylmethyl)-2-fluoro-4-methyl-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide;1H-Indeno[5,4-f]quinoline-7-carboxamide, 3-fluoro-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-N-(3H-imidazo[4,5-b]pyridin-2-ylmethyl)-1,4a,6a-trimethyl-2-oxo-, (4aS,4bS,6aS,7S,9aS,9bS,11aR)-;MK0773;MK 0773;PF 05314882;PF-05314882;PF05314882;MK 0773,MK0773 | | CAS: | 606101-58-0 | | MF: | C27H34FN5O2 | | MW: | 479.59 | | EINECS: | | | Product Categories: | | | Mol File: | 606101-58-0.mol |  |
| | MK-0773 Chemical Properties |
| Boiling point | 754.2±60.0 °C(Predicted) | | density | 1.31±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : 33.33 mg/mL (69.50 mM; Need ultrasonic) | | form | Powder | | pka | 10.29±0.40(Predicted) | | color | Light yellow to yellow |
| | MK-0773 Usage And Synthesis |
| Uses | MK-0773 is a selective androgen receptor modulator designed to improve muscle function while minimizing effects on other tissues. Furthermore, MK-0773 is useful in the enhancement of weakened muscle tone and the treatment of conditions caused by androgen deficiency or which can be ameliorated by androgen administration, including osteoporosis, osteopenia, glucocorticoid-induced osteoporosis, periodontal disease, bone fracture, bone damage following bone reconstructive surgery, sarcopenia, frailty, aging skin, male hypogonadism, postmenopausal symptoms in women, atherosclerosis, hypercholesterolemia, hyperlipidemia, obesity, aplastic anemia and other hematopoietic disorders, inflammatory arthritis and joint repair, HIV-wasting, prostate cancer, benign prostatic hyperplasia (BPH), abdominal | | target | androgen receptor |
| | MK-0773 Preparation Products And Raw materials |
| Raw materials | 1H-Indeno[5,4-f]quinoline-7-carboxylic acid, 3-fluoro-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1,4a,6a-triMethyl-2-oxo-, (4aS,4bS,6aS,7S,9aS,9bS,11aR)- |
|